New
Case Dismissed: Appeals Court Slams Expert Witness In Diabetes Drug Lawsuits
Multi-district litigation over the diabetes drug saxagliptin, a case that combined more than 80 suits from around the country, has failed because the plaintiffs’ sole expert witness was unreliable and did not show a causal link between the medication and …
